Rick Young, Ph.D.
MIT Professor of Biology, Member, Whitehead Institute
Dr. Rick Young studies gene regulatory circuitry in health and disease. His research accomplishments range from the development of genome-wide analysis technologies to the discovery of core regulatory circuitry of human embryonic stem cells. He has served as an advisor to the National Institutes of Health, the World Health Organization, the Vatican and numerous scientific societies and journals. Dr. Young has founded and advised companies in the biotechnology and pharmaceutical industry and is currently a member of the Board of Directors of Syros Pharmaceuticals, Camp4 Therapeutics, Omega Therapeutics and Dewpoint Therapeutics.
Dr. Young received his Ph.D. in Molecular Biophysics and Biochemistry at Yale University, conducted postdoctoral research at Stanford University, and joined Whitehead Institute and MIT in 1984.